Your session is about to expire
← Back to Search
Oncology Dashboard for Sarcoma Management
N/A
Waitlist Available
Led By Vinod Ravi
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with sarcoma on active chemotherapy/targeted therapy
>= 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial will test whether a tool called an "oncology dashboard" can help patients and doctors manage cancer treatment better.
Who is the study for?
This trial is for adult sarcoma patients who are not being treated at MDACC but get their follow-up imaging there. They must have been on the same treatment for at least 6 weeks, with stable or mildly progressive disease, and plan to continue it for another 6-8 weeks. They need a history of regular imaging on the affected area and an ECOG performance status better than 4.Check my eligibility
What is being tested?
The study tests if using an 'oncology dashboard'—a tool that displays patient cancer treatment data—can help patients understand their condition better and improve how doctors manage care. It involves best practices, questionnaires, and informational interventions.See study design
What are the potential side effects?
Since this trial focuses on information management rather than medication or invasive procedures, traditional side effects like those seen with drugs are not expected. However, there may be indirect effects related to changes in patient understanding or clinical decision-making.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am currently receiving chemotherapy or targeted therapy for sarcoma.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to complete medical oncology review (oncology workflow)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group II (standard of care)Experimental Treatment2 Interventions
Patients receive standard of care.
Group II: Group I (oncology dashboard)Experimental Treatment2 Interventions
Radiologist records information from patient's recent scan into oncology dashboard. Patients view images of how disease may have changed over time on oncology dashboard.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,971 Previous Clinical Trials
1,787,145 Total Patients Enrolled
55 Trials studying Sarcoma
18,161 Patients Enrolled for Sarcoma
National Cancer Institute (NCI)NIH
13,658 Previous Clinical Trials
40,924,455 Total Patients Enrolled
453 Trials studying Sarcoma
230,007 Patients Enrolled for Sarcoma
Vinod RaviPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
6 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to walk or care for myself.My cancer measurements are consistent and done while on the same treatment, unless my cancer has worsened.I am currently receiving chemotherapy or targeted therapy for sarcoma.I have had 3 or more scans of the same area, each 6 weeks apart.I will continue my current treatment for the next 6-8 weeks.My disease is not worsening significantly.I will have my follow-up scans at MD Anderson Cancer Center.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Group II (standard of care)
- Group 2: Group I (oncology dashboard)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment period for this experiment still open to volunteers?
"Affirmative. According to the information housed on clinicaltrials.gov, this trial is presently accepting registrations from potential participants. It was first advertised on October 1st 2015 and updated on August 22nd 2022; as of now, 75 individuals are required at one medical centre."
Answered by AI
What is the total population size of participants in this research?
"Affirmative. According to clinicaltrials.gov, this medical research project is actively seeking participants and has been live since October 1st 2015 with its most recent edit occurring on August 22nd 2022. 75 subjects are required from a single clinic."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger